Home » Stocks » VECT

VectivBio Holding AG (VECT)

Stock Price: $24.23 USD 7.23 (42.53%)
Updated Apr 9, 2021 4:00 PM EDT - Market closed
Market Cap 824.17M
Revenue (ttm) n/a
Net Income (ttm) -59.94M
Shares Out 34.01M
EPS (ttm) -1.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 9
Last Price $24.23
IPO Price $17.00
Change ($) 7.23
Change (%) 42.53%
Day's Open -
Day's Range 19.32 - 37.47
Day's Volume -
52-Week Range 0.00 - 37.47

News

Hide News

VectivBio Holding AG, (“Vectiv” or “VectivBio”) (Nasdaq: VECT), a clinical stage biopharmaceutical...

1 day ago - GlobeNewswire

VectivBio Holding, a Swiss Phase 3 biotech developing therapies for rare gastrointestinal disorders, filed on Friday with the SEC to raise up to $100 million in an initial public offering.

3 weeks ago - NASDAQ

VectivBio Holding AG has filed to go public with an IPO on the NASDAQ.

3 weeks ago - SEC

About VECT

VectivBio Holding is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need. Our goal is to become a leading, patient-centric, fully integrated global rare disease company. Our current product pipeline is focused on rare gastrointestinal, or GI, disorders, and we intend to in-license or acquire additional transformational, differentiated rare disease assets. Our product candidate, apraglutide, i... [Read more...]

Stock Exchange
NASDAQ
Ticker Symbol
VECT
Full Company Profile

Financial Performance

Financial Statements